Genotypes of N-acetyltransferase-2 and risk of bladder cancer: A case- control study

Journal of Urology

Volumn 161, Issue 5, 1999, Pages 1672-1675

  Filiadis, Ioannis F ^a   Georgiou, Ioannis ^a,b   Alamanos, Yannis ^a   Kranas, Vasilis ^a   Giannakopoulos, Xenophon ^a   Lolis, Dimitrios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Bladder cancer; N acetyltransferase 2 (NAT 2); Risk genotypes

Indexed keywords

ACYLTRANSFERASE;

ACETYLATION; ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK;

EID: 0032850119     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)69002-7     Document Type: Article

References (19)

1. World Cancer Research Fund and American Institute for Cancer Research.: Bladder cancers. In: Food, Nutrition and the Prevention of Cancer: A Global Perspective. 1st edition. Menasha WI: Banta Book Group, vol. 18, 4.18, pp. 338-361, 1997.
2. Lower, G. M.: Concepts in causality: chemically induced human urinary bladder cancer. Cancer, 49: 1056, 1982.
3. Viel, J. F. and Challier, B.: Bladder cancer among French farmers: does exposure to pesticides in vineyards play a part? Occup. Environ. Med., 52: 587, 1995.
4. Weber. W. W.: Pharmacogenetics. Oxford monographs on medical genetics; no. 32, pp.189-201, 1997.
5. Cartwright, R. A., Glasham, R. W., Rogers, H. J., Ahmed, R. A., Hall, D. B., Higgins, E. and Kahn, M. A.: The role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet, 2: 842, 1982.
6. Weber, W. W and Hein, D. W.: N-acetylation pharmacogenetics. Pharmacol. Rev., 37: 25, 1985.
7. Agundez, J. A. G., Martinez, C., Olivera, M., Ledesma, M. C., Ladero, J. M. and Benitez, J.: Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population. Clin. Pharmacol. Ther., 56: 202, 1994.
8. Blum, M., Demiere, A., Grant, D. M., Heim, M. and Meyer, U. A.: Molecular mechanisms of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA, 88: 5237, 1991.
9. Hickman, D. and Sim, E.: N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol., 42: 1007, 1991.
10. Hickman, D., Risch, A., Buckle, V., Spurr, N. K., Jeremiah, S. J., McCarthy, A. and Sim, E.: Chromosomal localization of human genes for arylamine-N-acetyltransferase. Biochem. J., 297: 441, 1994.
11. Taylor, J. W.: Simple estimation of population attributable risk from case-control studies. Am. J. Epidemiol., 106: 260, 1977.
12. Kato, R. and Yamazoe Y.: Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification. Drug. Metab. Rev., 26: 413, 1994.
13. Kadlubar, F. F.: DNA adducts of carcinogenic aromatic amines. In: DNA Adducts Identification and Significance. Edited by Hemminki, K., Dipple, A., Shuker, D. E. G., Kadlubar, F. F., Segerback, D. and Bartch, H. IARC Sci. Pub., vol. 125, pp. 199-216, 1994.
14. Theodorescu, D.: Commentary on genetic prognostic markers for transitional cell carcinoma of the bladder: From microscopes to molecules. J. Urol., 155: 2, 1996.
15. Droller, M. J. A.: Comment in the Year Book of Urology. Edited by Dekernion, J. B. and Howards, S. S. St Louis: Mosby, vol. 19, p. 155, 1996.
16. Hirvonen, A., Nylund, L., Kociba, P., Husgafvel-Pursiainen, K. and Vainio, H.: Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis, 15: 813, 1994.
17. Risch, A., Wallace, D. M., Bathers, S. and Sim, E.: Slow N-acetylation genotype is a suspeptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet., 4235: 231, 1995.
18. Gabbani, G., Hou, S. M., Nardini, B., Marchioro, M., Lambert, B. and Clonfero, E.: GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis, 17: 1677, 1996.
19. Nakayama, T., Zaman, M. M. and Tanaka, H.: Reporting of attributable and relative risks, 1996-1997. Lancet, 351: 1179, 1998.